Research Program Leaders

More than 300 members, representing 42 University of Pittsburgh departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center CCSG research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer risk, outcomes and prevention in cancer.

Research Program Leaders

• Adam Brufsky, MD, PhD
  Co-Leader, Cancer Therapeutics Program
• Ronald Buckanovich, MD, PhD
  Co-Leader, Cancer Biology Program
• James Herman, MD
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• Marci Lee Nilsen, PhD, MSN, RN, CHPN, FAAN
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• Steffi Oesterreich, PhD
  Co-Leader, Cancer Biology Program
• Patricia Opresko, PhD
  Co-Leader, Genome Stability Program
• Roderick O’Sullivan, PhD
  Co-Leader, Genome Stability Program
• Anwaar Saeed, MD
  Co-Leader, Cancer Therapeutics Program
• Dario Vignali, PhD
  Co-Leader, Cancer Immunology and Immunotherapy Program
• Peter Wipf, PhD
  Co-Leader, Cancer Therapeutics Program
• Jian-Min Yuan, MD, PhD
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• Hassane Zarour, MD
  Co-Leader, Cancer Immunology and Immunotherapy Program